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journal homepage: http: / /www.kjms-onl ine.comEDITORIALThis special issue covers topics that were presented at the
International Conference on Food and Drug Safety
Assessment on April 15e16, 2011, sponsored by Kaohsiung
Medical University, Taiwan and the National Center for
Toxicological Research, Food and Drug Administration,
USA. Subsequent to the much-publicized episode of plas-
ticizer contamination in food and drug preparations, the
safety of food and drugs has becoming increasingly
important to the general public. Therefore, review arti-
cles on the toxic effects of plasticizers on human health
are also included.
The current issue comes at the right time to address new
tools and opportunities that could be used to increase our
understanding of the cellular, molecular, and genetic
mechanisms by which environmental exposure exerts its
effects. The actions of toxic substances, including the
misconception of zero tolerance in food and drug safety,
could be better understood. The globalization of food and
medical products may create shifts in regulatory compliance
so that could fill the gaps in food andmedical product safety.
This issue begins with Patel and Miller [1] discussing how
regulatory science plays a vital role in protecting and
promoting global public health by providing the scientific
basis that ensures that food and medical products are safe.
The article by Li et al. [2] reviews the major food safety
episodes that occurred in Taiwan during the past decade
and discusses the necessity of establishing a well-
coordinated, harmonized system for domestic and inter-
national collaboration on standards and regulations. Li and
Ko [3] then give a succinct account of the recent plasticizer
incident that happened in May 2011 and its health impacts
in Taiwan. Next, two articles by Wang et al. [4] and Tsai
et al. [5] suggest the possible tumorigenic mechanisms of
phthalates and their associations with phthalate exposure
and asthma. Based on epidemiological data on human
exposure to phthalates, animal carcinogenicity data, gen-
otoxicity, and cellular mechanisms, Wang et al. [4]
hypothesize that the aryl hydrocarbon receptor (AhR) and
its downstream signaling cascade promote phthalate-
induced tumorigenesis. Tsai et al. [5] review epidemiolog-
ical evidence on the relationship between phthalate
exposure and asthma, as well as allergic diseases, and the
adjuvant effects of phthalates on the immune response and
airway remodeling. Both reviews urge the importance of
conducting further extensive studies on this emerging
public health concern.1607-551X/$36 Copyright ª 2012, Elsevier Taiwan LLC. All rights reserv
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broadly covers environmental concerns regarding
endocrine-disrupting chemicals (EDCs) and dioxin in the
environment. The articles by Kuo et al. [6] and Sun et al. [7]
review the effects of EDCs on immunomodulation and
allergic responses, respectively. Kuo et al. [6] describe the
effects of EDCs on the immune system (e.g., the synthesis
of cytokines, immunoglobulins, and inflammatory media-
tors and the activation and survival of immune cells). The
evidence indicates that the dysfunction of the immune
system caused by EDCs may lead to the attenuation of
immunity against infection or the hyperreactivity of
immune responses. The article by Sun et al. [7] focuses on
the effects of two alkylphenolic EDCs (4-nonylphenol and 4-
octylphenol) on several key cell types involved in allergic
inflammation. The review by Yoshimura [8] details issues
with Yusho disease that have manifested over the last 43
years, including the accumulation of dioxin and the intake
level of dioxin via food in Japan. The launch of a project
that will be undertaken by the Japanese government
regarding the environment and children is also introduced.
The closing article by Lin et al. [9] raises caution about
the emerging potential threat of toxicity due to
nanotechnology-related products. The article examines the
safety of quantum dot 705 in the kidneys, indicating that
renal mitochondria appear to be the target of QD 705
toxicity. The safety of nanoparticles in various products
deserves careful and systematic assessment regarding their
different characteristics in pharmacological and pharma-
cokinetic profiles, as is conducted for conventionally
prepared products. The safety of nanotechnology-
manufactured products should be carefully evaluated.References
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